Clinical Trial Update: 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the 68Ga-PFD3 PET imaging tracer for diagnosing and evaluating small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• 68Ga-PFD3 PET tracer (68Ga-PFD3)

Snippet

Sponsor: Peking University First Hospital | Conditions: SCLC, SCLC, Extensive Stage | Phase 1, Phase 2 | Status: RECRUITING